Gilead Sciences has taken a major step towards ... and Zimbabwe. The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Gilead Sciences (GILD) been one of those stocks this year? Let's take a ...

Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.

Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing ...

Gilead Sciences’ efforts to develop better HIV ... its global presence to address the unmet demand for advanced medical devices. Within Cardiovascular, Medtronic is gaining market share, banking ...

Gilead Sciences posted robust revenue and EPS growth ... maintaining a strong market position by addressing unmet medical needs and ensuring competitive pricing strategies. Gilead's upturn ...

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results, a robust HIV franchise, and an imminent lenacapavir commercialization by summer 2025. Lenacapavir PrEP regimen, with 100% ...

Hi, everyone. My name is Daina Graybosch. I'm a Senior Analyst here at Leerink Partners, covering largely immuno-oncology and also Gilead, which is broader than immuno-oncology. But today ...